IMMUTEP COO discloses shares and performance rights
IMMUTEP Ltd Chief Operating Officer Deanne Diem Miller reported her initial ownership on a Form 3.
Rhea-AI Filing Summary
IMMUTEP Ltd Chief Operating Officer Deanne Diem Miller reported her initial ownership on a Form 3. She directly holds 2,867,305 Ordinary Shares. In addition, she holds 1,800,000 performance rights, each giving a right to receive Ordinary Shares at an exercise price of $0.0000 per share.
These performance rights are structured in three equal tranches of 600,000 underlying Ordinary Shares each, scheduled to vest on December 1, 2026, December 1, 2027, and December 1, 2028. Vesting of the later tranches depends on Ms. Miller achieving specified key performance indicators at the applicable vesting dates.
Positive
- None.
Negative
- None.
Insider Trade Summary
4 transactions reported
Mixed
4 txns
Insider
Miller Deanne Diem
Role
Chief Operating Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Performance rights (right to receive) | -- | -- | -- |
| holding | Performance rights (right to receive) | -- | -- | -- |
| holding | Performance rights (right to receive) | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
Holdings After Transaction:
Performance rights (right to receive) — 1,800,000 contracts (Direct);
Ordinary Shares — 2,867,305 shares (Direct)
Footnotes (3)
- F1. Granted on December 5, 2024. 600,000 performance rights will vest on December 1, 2026 and the vesting of the remaining 1,200,000 performance rights is dependent on Ms. Miller achieving key performance indicators at the applicable vesting date.
- F2. Granted on December 5, 2024. 600,000 performance rights will vest on December 1, 2027 and the vesting of the remaining 600,000 performance rights is dependent on Ms. Miller achieving key performance indicators at the applicable vesting date.
- F3. Granted on December 5, 2024. 600,000 performance rights will vest on December 1, 2028 and the vesting is dependent on Ms. Miller achieving key performance indicators at the applicable vesting date.
Key Figures
Ordinary Shares held: 2,867,305 shares
Total performance rights: 1,800,000 rights
First performance rights tranche: 600,000 underlying shares
+3 more
6 metrics
Ordinary Shares held
2,867,305 shares
Direct ownership following transactions
Total performance rights
1,800,000 rights
Rights to receive Ordinary Shares at $0.0000
First performance rights tranche
600,000 underlying shares
Scheduled to vest on December 1, 2026
Second performance rights tranche
600,000 underlying shares
Scheduled to vest on December 1, 2027; KPI dependent for remaining rights
Third performance rights tranche
600,000 underlying shares
Scheduled to vest on December 1, 2028; KPI dependent
Exercise price of performance rights
$0.0000 per share
Applies to all reported performance rights
Key Terms
Performance rights, Ordinary Shares, vesting, key performance indicators
4 terms
Performance rights financial
"Performance rights (right to receive)"
Performance rights are conditional awards that give employees or executives the promise of receiving company shares or cash only if the business meets specific targets or survives for a set period. They work like a bonus you only get when certain goals are hit, so they matter to investors because they can increase the number of shares outstanding (dilution), signal management’s incentives and confidence in future results, and affect per-share earnings and valuation.
vesting financial
"600,000 performance rights will vest on December 1, 2026"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
key performance indicators financial
"dependent on Ms. Miller achieving key performance indicators"
Key performance indicators are specific measurements used to track how well a person, team, or organization is achieving its goals. They act like report cards, providing clear signs of progress or areas needing improvement. For investors, KPIs help assess the health and future potential of a business by highlighting its most important strengths and challenges.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity holdings did IMMUTEP (IMMP) COO Deanne Miller report on this Form 3?
Deanne Diem Miller reported direct ownership of 2,867,305 Ordinary Shares of IMMUTEP Ltd. She also reported 1,800,000 performance rights, each representing a right to receive Ordinary Shares, providing significant equity-based exposure alongside her existing shareholding.
How many performance rights does IMMUTEP (IMMP) COO Deanne Miller hold and how are they structured?
She holds 1,800,000 performance rights, split into three equal tranches of 600,000 underlying Ordinary Shares each. All carry an exercise price of $0.0000 per share and are scheduled to vest over several future dates, subject to performance conditions.
When do Deanne Miller’s IMMUTEP (IMMP) performance rights vest?
The performance rights vest in three stages: 600,000 on December 1, 2026, 600,000 on December 1, 2027, and 600,000 on December 1, 2028. Each vesting date represents a potential future issuance of Ordinary Shares to her.
Are Deanne Miller’s IMMUTEP (IMMP) performance rights subject to performance conditions?
Yes. The footnotes state that vesting of 1,200,000 performance rights tied to 2027 and 2028 dates depends on Ms. Miller achieving key performance indicators at the applicable vesting dates. This links a large part of her potential equity to company and role performance.
What is the exercise price of IMMUTEP (IMMP) COO Deanne Miller’s performance rights?
The performance rights carry an exercise price of $0.0000 per underlying Ordinary Share. This means that, upon vesting and satisfaction of conditions, shares can be received without additional cash outlay, aligning compensation with equity value rather than purchase cost.
AI-generated analysis. How Rhea-AI works. Not financial advice.
